APPLICATION
ANDA203883
TYPE
ANDA
ORIGINAL APPROVAL
2014-03-24
LATEST ACTION
2015-09-17
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
ADENOSINEDiscontinued
ADENOSINE 60MG/20ML (3MG/ML) · SOLUTION · INTRAVENOUS
ADENOSINEDiscontinued
ADENOSINE 90MG/30ML (3MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2015-09-17Labeling · Supplement 1 · standardAP
2014-03-24UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.